Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Genpact
G
$6.07B
| $2.47M | ﹤0.01% |
76,736
-85,844
| -53% | -$2.77M |
|
1952
Crescent Capital BDC
CCAP
$414M
| $2.46M | ﹤0.01% |
+131,158
| New | +$2.34M |
|
1953
California Water Service
CWT
$3.05B
| $2.46M | ﹤0.01% |
50,731
-31,391
| -38% | -$1.53M |
|
|
RNAM
1954
CALL
DELISTED
Avidity Biosciences
RNAM
| $2.45M | ﹤0.01% |
+60,000
| New | +$1.72M |
|
1955
GXO Logistics
GXO
$5.82B
| $2.45M | ﹤0.01% |
48,525
-118,243
| -71% | -$5.97M |
|
1956
Cellebrite
CLBT
$3.76B
| $2.44M | ﹤0.01% |
204,262
-99,740
| -33% | -$1.11M |
|
1957
IAMGOLD
IAG
$8.55B
| $2.44M | ﹤0.01% |
649,982
-217,689
| -25% | -$830K |
|
1958
Affirm
AFRM
$26.2B
| $2.43M | ﹤0.01% |
80,534
-23,456
| -23% | -$752K |
|
1959
VanEck Junior Gold Miners ETF
GDXJ
$7.33B
| $2.43M | ﹤0.01% |
57,686
-165,352
| -74% | -$7.05M |
|
1960
Alight
ALIT
$517M
| $2.43M | ﹤0.01% |
16,433
-13,203
| -45% | -$2.2M |
|
1961
FirstService
FSV
$6.31B
| $2.42M | ﹤0.01% |
15,903
-12,498
| -44% | -$1.89M |
|
1962
Gold Fields
GFI
$30.5B
| $2.42M | ﹤0.01% |
162,515
+1,305
| +0.8% | +$21.2K |
|
1963
Weatherford International
WFRD
$6.33B
| $2.41M | ﹤0.01% |
19,669
-98,706
| -83% | -$11.8M |
|
|
AGS
1964
DELISTED
PlayAGS
AGS
| $2.41M | ﹤0.01% |
209,431
+153,280
| +273% | +$1.58M |
|
|
SUM
1965
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.4M | ﹤0.01% |
65,584
-64,394
| -50% | -$2.53M |
|
1966
Twist Bioscience
TWST
$6.19B
| $2.4M | ﹤0.01% |
48,619
-84,068
| -63% | -$3.43M |
|
|
CNR
1967
Core Natural Resources Inc
CNR
$4.05B
| $2.39M | ﹤0.01% |
23,441
-17,661
| -43% | -$1.61M |
|
1968
Merit Medical Systems
MMSI
$5.11B
| $2.39M | ﹤0.01% |
27,804
-33,374
| -55% | -$2.62M |
|
1969
Cerus
CERS
$433M
| $2.39M | ﹤0.01% |
1,355,294
-65,339
| -5% | -$117K |
|
1970
CALL
Ionis Pharmaceuticals
IONS
$9.06B
| $2.38M | ﹤0.01% |
50,000
-85,000
| -63% | -$3.49M |
|
1971
Tanger
SKT
$4.68B
| $2.37M | ﹤0.01% |
87,485
-32,435
| -27% | -$892K |
|
1972
JELD-WEN Holding
JELD
$124M
| $2.37M | ﹤0.01% |
175,745
-79,978
| -31% | -$1.34M |
|
1973
SSR Mining
SSRM
$5.52B
| $2.36M | ﹤0.01% |
524,316
+58,016
| +12% | +$298K |
|
1974
Gentex
GNTX
$4.99B
| $2.36M | ﹤0.01% |
69,903
-161,944
| -70% | -$5.59M |
|
1975
CNX Resources
CNX
$5.33B
| $2.35M | ﹤0.01% |
96,874
-177,429
| -65% | -$4.33M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.